News and Announcements
Altech Chemicals HPA Project Detailed Design Update
- Published September 21, 2016 2:35PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
21st September 2016, ASX Announcement
Highlights:
- German M+W Group well advanced on HPA plant detailed design and engineering
- Leading global engineering and construction firm with extensive Asian experience
- Established Singapore and Malaysian offices, with extensive Malaysian construction experience
German M+W Group well advanced on HPA plant detailed design and engineering work that is currently being undertaken by German firm M+W Group in Stuttgart, Germany, for its proposed Malaysian high purity alumina (HPA) plant.
M+W Group is leading global high-tech engineering firm with around 6,000 employees worldwide. Established in 1912, M+W Group has a strong presence in Asia with regional offices in both Singapore and Penang, Malaysia.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
